Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.
about
Milk proteins, peptides, and oligosaccharides: effects against the 21st century disordersNetworking galore: intermediate filaments and cell migrationLactoferrin from Milk: Nutraceutical and Pharmacological PropertiesSILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrinProteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS ApproachLactoferrin deficiency promotes colitis-associated colorectal dysplasia in mice.Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer.Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.Chemopreventive role of food-derived proteins and peptides: A review.Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.Human lactoferrin induces asthmatic symptoms in NC/Nga mice.Intermediate Filaments at the Junction of Mechanotransduction, Migration, and Development.Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9.Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia.miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.Lactoferrin administration into the nostril alleviates murine allergic rhinitis and its mechanisms.TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer
P2860
Q27023113-3618EBAD-4FE2-4143-866A-7025BCB175C0Q27693294-89D45ED0-07BD-406A-AD79-2B9BBB3BB652Q28077296-A040127F-4ECE-466B-855A-41DF3650E985Q28541808-54277A2D-0982-4885-9579-5E3224472C48Q28550766-83607DF2-D53F-47C2-B922-E36B029F75E9Q33946055-AD96719D-DC8E-4E41-9AF3-6E29410C32E0Q35742217-4F3E33BB-7254-4BDF-A569-A49BA9B3E753Q37108220-0D398123-A4C3-4962-9C77-A7C63CEF7290Q37720601-DDFBEB0F-34C5-418A-99A5-8A8168BA2259Q38632533-AC62D264-4EA0-4C11-97CD-B8E54E3F4CFBQ38940037-A2BCA962-B027-49E9-85F9-A0ACBD8709EEQ38942781-42799DDC-C89E-4E49-854E-B1D65285FABBQ40095508-7DD004A6-29E0-4291-8DCF-520E47806D78Q41672923-9836A247-4139-4535-993B-E28076CEA509Q42203390-FF5C6341-94C9-4690-BB0C-7541331DDC38Q43987274-FE04B358-C2C5-4E7F-9AC6-4FCAB502F82EQ44424639-76EADF3D-EEFC-4379-BC1C-5B7553054F6BQ46166167-74EC0D45-45BE-44C9-9556-2D532849B689Q50020811-4827E3D5-2E13-46E8-83A7-2E696562895DQ59126382-210C2FAF-EDED-4444-AE8F-FC47E9FDB248
P2860
Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Lactotransferrin acts as a tum ...... T through multiple mechanisms.
@en
Lactotransferrin acts as a tum ...... T through multiple mechanisms.
@nl
type
label
Lactotransferrin acts as a tum ...... T through multiple mechanisms.
@en
Lactotransferrin acts as a tum ...... T through multiple mechanisms.
@nl
prefLabel
Lactotransferrin acts as a tum ...... T through multiple mechanisms.
@en
Lactotransferrin acts as a tum ...... T through multiple mechanisms.
@nl
P2093
P2860
P356
P1433
P1476
Lactotransferrin acts as a tum ...... T through multiple mechanisms.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.434
P407
P577
2012-10-15T00:00:00Z
P5875
P6179
1020283135